Cancer Immunology, Immunotherapy Issues Research Articles in April 2024
June 18, 2024
June 18, 2024
BASEL, Switzerland, June 18 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles on the following topics in its April 2024 edition (Vol. 73, Issue 4):
* Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer
* Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China
* . . .
* Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer
* Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China
* . . .